Acetohydroxamic Acid
1 NDC across 1 manufacturer|0 Generic,1 Brand
Acetohydroxamic Acid is used to treat urinary tract infections, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 31, 1983. In 2024, Medicare Part D spent $651K on Acetohydroxamic Acid across 1,360 claims for 242 beneficiaries.
Acetohydroxamic Acid is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $6.66 to $6.66 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$6.66 – $6.66
per EA
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ACETOHYDROXAMIC ACID
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
LITHOSTAT 250 MG TABLET | $6.6632 per EA | — |
Frequently Asked Questions
What is Acetohydroxamic Acid used to treat?
Acetohydroxamic Acid is used to treat urinary tract infections, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Acetohydroxamic Acid?
In 2024, Medicare Part D spent $651K on Acetohydroxamic Acid across 1,360 claims for 242 beneficiaries.
How many Acetohydroxamic Acid products are on the market?
The Acetohydroxamic Acid drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Acetohydroxamic Acid?
NADAC reference prices for Acetohydroxamic Acid range from $6.6632 to $6.6632 per EA.
Which manufacturers make Acetohydroxamic Acid?
1 manufacturer lists Acetohydroxamic Acid in NADAC. Ranked by number of NDCs, the largest are Mission Pharmacal Company (1).